Neuronetics is trading 11.06% up at $2.41 after reporting robust second-quarter 2026 financial results. The company reported Q2 2026 revenue of $41.6 million, surpassing analyst expectations of $40.17 million. Neuronetics significantly narrowed its net loss to $0.05 per share, outperforming analyst estimates of a $0.123 loss. Adjusted EBITDA turned positive at $0.3 million, compared to a $5.6 million loss in the prior year.